Sergiu Ioan

Mr. Sergiu Ioan

Department of Biology, Faculty of Biology, “Alexandru Ioan Cuza” University, 700505 Iasi, Romania
orcid

Research Focus & Metrics

Academic Career Length

7Years (2020-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
30 July 2020 in Microorganisms
Verified
Journal Article
Open access
PDF file
OIOvidiu Dumitru Ilie
Ovidiu Dumitru Ilie
RCRoxana-Oana Cojocariu
Roxana-Oana Cojocariu
Alin Stelian CiobicăAlin Stelian Ciobică
Alin Stelian Ciobică
SISergiu Ioan
Sergiu Ioan
IMIoannis Mavroudis
Ioannis Mavroudis
Bogdan DorofteiBogdan Doroftei
Bogdan Doroftei
Since mid-November 2019, when the first SARS-CoV-2-infected patient was officially reported, the new coronavirus has affected over 10 million people from which half a million died during this short period. There is an urgent need to monitor, predict, and restrict COVID-19 in a more efficient manner. This is why Auto-Regressive Integrated Moving Average (ARIMA) models have been developed and used to predict the epidemiological trend of COVID-19 in Ukraine, Romania, the Republic of Moldova, Serbia, Bulgaria, Hungary, USA, Brazil, and India, these last three countries being otherwise the most affected presently. To increase accuracy, the daily prevalence data of COVID-19 from 10 March 2020 to 10 July 2020 were collected from the official website of the Romanian Government GOV.RO, World Health Organization (WHO), and European Centre for Disease Prevention and Control (ECDC) websites. Several ARIMA models were formulated with different ARIMA parameters. ARIMA (1, 1, 0), ARIMA (3, 2, 2), ARIMA (3, 2, 2), ARIMA (3, 1, 1), ARIMA (1, 0, 3), ARIMA (1, 2, 0), ARIMA (1, 1, 0), ARIMA (0, 2, 1), and ARIMA (0, 2, 0) models were chosen as the best models, depending on their lowest Mean Absolute Percentage Error (MAPE) values for Ukraine, Romania, the Republic of Moldova, Serbia, Bulgaria, Hungary, USA, Brazil, and India (4.70244, 1.40016, 2.76751, 2.16733, 2.98154, 2.11239, 3.21569, 4.10596, 2.78051). This study demonstrates that ARIMA models are suitable for making predictions during the current crisis and offers an idea of the epidemiological stage of these regions.

21 March 2022 in Journal of Clinical Medicine
Verified
Journal Article
Open access
PDF file
Bogdan DorofteiBogdan Doroftei
Bogdan Doroftei
OIOvidiu Dumitru Ilie
Ovidiu Dumitru Ilie
Nicoleta AntonNicoleta Anton
Nicoleta Anton
SISergiu Ioan
Sergiu Ioan
CICiprian Gavrila Ilea
Ciprian Gavrila Ilea
Background: COVID-19 caused by the Severe Acute Respiratory Syndrome Coronavirus 2 placed the health systems around the entire world in a battle against the clock. While most of the existing studies aimed at forecasting the infections trends, our study focuses on vaccination trend(s). Material and methods: Based on these considerations, we used standard analyses and ARIMA modeling to predict possible scenarios in Romania, the second-lowest country regarding vaccinations from the entire European Union. Results: With approximately 16 million doses of vaccine against COVID-19 administered, 7,791,250 individuals had completed the vaccination scheme. From the total, 5,058,908 choose Pfizer–BioNTech, 399,327 Moderna, 419,037 AstraZeneca, and 1,913,978 Johnson & Johnson. With a cumulative 2147 local and 17,542 general adverse reactions, the most numerous were reported in recipients of Pfizer–BioNTech (1581 vs. 8451), followed by AstraZeneca (138 vs. 6033), Moderna (332 vs. 1936), and Johnson & Johnson (96 vs. 1122). On three distinct occasions have been reported >50,000 individuals who received the first or second dose of a vaccine and >30,000 of a booster dose in a single day. Due to high reactogenicity in case of AZD1222, and time of launching between the Pfizer–BioNTech and Moderna vaccine could be explained differences in terms doses administered. Furthermore, ARIMA(1,1,0), ARIMA(1,1,1), ARIMA(0,2,0), ARIMA(2,1,0), ARIMA(1,2,2), ARI-MA(2,2,2), ARIMA(0,2,2), ARIMA(2,2,2), ARIMA(1,1,2), ARIMA(2,2,2), ARIMA(2,1,1), ARIMA(2,2,1), and ARIMA (2,0,2) for all twelve months and in total fitted the best models. These were regarded according to the lowest MAPE, p-value (p < 0.05, p < 0.01, and p < 0.001) and through the Ljung–Box test (p < 0.05, p < 0.01, and p < 0.001) for autocorrelations. Conclusions: Statistical modeling and mathematical analyses are suitable not only for forecasting the infection trends but the course of a vaccination rate as well.